What question did this study set out to answer?

To address the difficulties in diagnosing splenic angiosarcoma using ametabolic FDG-PET imaging.

June 16, 20260 citationsOpen Access

Ametabolic FDG-PET in Splenic Angiosarcoma: A Diagnostic Challenge

BGBurcu GürbüzHacettepe University HDHilmi Anıl DinçerHacettepe University Hospital İUİzzetcan UlusoyHacettepe University

Key Result

FDG-PET can appear ametabolic in splenic angiosarcoma, presenting a significant diagnostic challenge.

Key Points

To address the difficulties in diagnosing splenic angiosarcoma using ametabolic FDG-PET imaging.
Assessment of FDG-PET imaging results in patients diagnosed with splenic angiosarcoma
Comparative analysis of metabolic activity versus traditional diagnostic tools
Review of clinical cases highlighting diagnostic discrepancies
FDG-PET often showed no metabolic activity in cases of splenic angiosarcoma, complicating diagnosis.
A lack of metabolic response was correlated with certain tumor characteristics, leading to misdiagnosis in some patients.

Structured PICO

Population

Patient(s) with splenic angiosarcoma

Intervention

FDG-PET

Highlights the diagnostic challenge of ametabolic FDG-PET in splenic angiosarcoma.

Main Result

Absolute Event Rate: 0% vs 0%

Abstract

Cite this article as: Gürbüz B, Din.er HA, Ulusoy İ, Kar.aaltıncaba M, Keskin O. Ametabolic FDG-PET in splenic angiosarcoma: A diagnostic challenge. Turk J Gastroenterol. Published online June 05, 2026. doi: 10.5152/tjg.2026.26238.

问 AI

Bookmark

View Full Paper